50 related articles for article (PubMed ID: 12485205)
41. The pharmacology of current anti-migraine drugs.
Peroutka SJ
Headache; 1990 Jan; 30(1 Suppl):5-11; discussion 24-8. PubMed ID: 1969855
[TBL] [Abstract][Full Text] [Related]
42. The link between glutamate and migraine.
Ramadan NM
CNS Spectr; 2003 Jun; 8(6):446-9. PubMed ID: 12858134
[TBL] [Abstract][Full Text] [Related]
43. Modulation of noradrenaline release in human cardiovascular tissues.
Göthert M
Pharmacol Toxicol; 2003 Apr; 92(4):156-9. PubMed ID: 12753416
[No Abstract] [Full Text] [Related]
44. New vistas on 5-HT receptors and migraine.
Peroutka SJ
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):191-7. PubMed ID: 1871321
[TBL] [Abstract][Full Text] [Related]
45. 5-HT receptor subtype-specific drugs and the cardiovascular system.
van Heuven-Nolsen D
Trends Pharmacol Sci; 1988 Dec; 9(12):423-5. PubMed ID: 3078080
[No Abstract] [Full Text] [Related]
46. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
McCall RB; Huff R; Chio CL; TenBrink R; Bergh CL; Ennis MD; Ghazal NB; Hoffman RL; Meisheri K; Higdon NR; Hall E
Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
[TBL] [Abstract][Full Text] [Related]
47. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.
Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R
Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158
[TBL] [Abstract][Full Text] [Related]
48. Migraine: pathophysiology, pharmacology, treatment and future trends.
Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
[TBL] [Abstract][Full Text] [Related]
49. Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
Mitsikostas DD; Tfelt-Hansen P
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):241-9. PubMed ID: 22934751
[TBL] [Abstract][Full Text] [Related]
50. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
Martin GR
Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
